Cas 503038-97-9,methyl 4-[(4-chloro-6-(2-indanyl-amino)-[1,3,5]triazin-2-yl-amino)-methyl]-benzoate

503038-97-9

Post Buying Request

Basic information

Product Name: methyl 4-[(4-chloro-6-(2-indanyl-amino)-[1,3,5]triazin-2-yl-amino)-methyl]-benzoate
Synonyms: methyl 4-[(4-chloro-6-(2-indanyl-amino)-[1,3,5]triazin-2-yl-amino)-methyl]-benzoate
CAS NO:503038-97-9
Molecular Formula:
Molecular Weight: 409.875
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: methyl 4-[(4-chloro-6-(2-indanyl-amino)-[1,3,5]triazin-2-yl-amino)-methyl]-benzoate(CAS DataBase Reference)
NIST Chemistry Reference: methyl 4-[(4-chloro-6-(2-indanyl-amino)-[1,3,5]triazin-2-yl-amino)-methyl]-benzoate(503038-97-9)
EPA Substance Registry System: methyl 4-[(4-chloro-6-(2-indanyl-amino)-[1,3,5]triazin-2-yl-amino)-methyl]-benzoate(503038-97-9)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 503038-97-9(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

503038-97-9 Suppliers

Recommended suppliers

503038-97-9 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 503038-97-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,0,3,0,3 and 8 respectively; the second part has 2 digits, 9 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 503038-97:
(8*5)+(7*0)+(6*3)+(5*0)+(4*3)+(3*8)+(2*9)+(1*7)=119
119 % 10 = 9
So 503038-97-9 is a valid CAS Registry Number.

503038-97-9Upstream product

503038-97-9Downstream Products

503038-97-9Relevant academic research and scientific papers

Design and synthesis of 4-[(s-triazin-2-ylamino)methyl]-N-(2-aminophenyl)-benzamides and their analogues as a novel class of histone deacetylase inhibitors

Paquin, Isabelle,Raeppel, Stephane,Leit, Silvana,Gaudette, Frederic,Zhou, Nancy,Moradei, Oscar,Saavedra, Oscar,Bernstein, Naomy,Raeppel, Franck,Bouchain, Giliane,Frechette, Sylvie,Woo, Soon H.,Vaisburg, Arkadii,Fournel, Marielle,Kalita, Ann,Robert, Marie-France,Lu, Aihua,Trachy-Bourget, Marie-Claude,Yan, Pu Theresa,Liu, Jianhong,Rahil, Jubrail,MacLeod, A. Robert,Besterman, Jeffrey M.,Li, Zuomei,Delorme, Daniel

, p. 1067 - 1071 (2008/09/18)

Inhibition of histone deacetylases (HDAC) is emerging as a new strategy in human cancer therapy. The synthesis and biological evaluation of a variety of 4-(heteroarylaminomethyl)-N-(2-aminophenyl)-benzamides is presented herein. From the different series

Inhibitors of histone deacetylase

-

, (2008/06/13)

The invention relates to the inhibition of histone deacetylase. The invention provides compounds and methods for inhibiting histone deacetylase enzymatic activity. The invention also provides compositions and methods for treating cell proliferative diseases and conditions.

Inhibitors of histone deacetylase

-

, (2008/06/13)

Inhibitors of histone deacetylase

-

, (2008/06/13)

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 503038-97-9